CMPX Compass Therapeutics, Inc.companySEC Filings & Insider Trading Activity 2026
Latest Compass Therapeutics, Inc. (CMPX) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on March 5, 2026, a 10-Q quarterly report filed on May 5, 2026, an 8-K current report filed on August 6, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Compass Therapeutics, Inc. (CMPX) (SEC CIK 1738021), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Go deeper on Compass Therapeutics, Inc.
Ask AI about CMPX filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.
Track institutional money. See which funds are building or cutting CMPX positions, quarter over quarter.
Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on CMPX.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Compass Therapeutics, Inc. (CMPX) 8-K current reports disclosing material events.
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Aug 6, 2026 | - | - | - |
8-K | Jul 1, 2026 | - | - | - |
8-K | Jun 23, 2026 | - | - | - |
8-K | Jun 11, 2026 | - | - | - |
8-K | May 5, 2026 | - | - | - |
10-Q | May 5, 2026 | Mar 31, 2026 | - | |
8-K | Apr 27, 2026 | - | - | - |
10-K | Mar 5, 2026 | Dec 31, 2025 | - | |
8-K | Mar 5, 2026 | - | Analysis | - |
8-K | Jan 6, 2026 | - | - | |
10-Q | Nov 5, 2025 | Sep 30, 2025 | - | |
10-Q | Aug 11, 2025 | Jun 30, 2025 | - | |
10-Q | May 8, 2025 | Mar 31, 2025 | - | |
10-K | Feb 27, 2025 | Dec 31, 2024 | - | |
10-Q | Nov 12, 2024 | Sep 30, 2024 | - | |
10-Q | Aug 12, 2024 | Jun 30, 2024 | - | |
SC 13G | Aug 2, 2024 | - | - | |
10-Q | May 13, 2024 | Mar 31, 2024 | - | |
10-K | Mar 21, 2024 | Dec 31, 2023 | - | |
SC 13G | Feb 1, 2024 | - | - | |
SC 13G | Nov 27, 2023 | - | - | |
10-Q | Nov 9, 2023 | Sep 30, 2023 | - | |
10-Q | Aug 3, 2023 | Jun 30, 2023 | - | |
10-Q | May 4, 2023 | Mar 31, 2023 | - | |
10-K | Mar 15, 2023 | Dec 31, 2022 | - |
13F Fund Holdings: Quarterly Trend
Latest: Q1 2026Aggregate CMPX share value held by 13F filers tracked by SignalX, by quarter.
- State Street Corp+1.80M (+37%)
- Citadel Advisors LLC+785.4K (+743%)
- Ameriprise Financial+773.6K (+94%)
- Bank of America Corp+599.2K (+225%)
- Goldman Sachs Group+478.0K (+31%)
- Blackstone Group4.27M (-70%)
- Millennium Management2.26M (-73%)
- FMR LLC (Fidelity)778.0K (-30%)
- M&T Bank749.2K (-98%)
- Wells Fargo & Co97.1K (-67%)
- Franklin Resources+66.6K
- Two Sigma Investments+33.1K
- U.S. Bancorp+77
- Vanguard Group Inc−8.05M
- JPMorgan Chase & Co−870.0K
- Invesco Ltd−63.9K
Source: 13F-HR filings on SEC EDGAR (aggregated from 149 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.
Frequently Asked Questions
What are the latest CMPX SEC filings in 2026?
Compass Therapeutics, Inc. (CMPX) has filed a 10-K annual report on March 5, 2026, a 10-Q quarterly report on May 5, 2026, an 8-K current report on August 6, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did CMPX file its most recent 10-K annual report?
Compass Therapeutics, Inc. (CMPX) filed its most recent 10-K annual report on March 5, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view CMPX 10-Q quarterly reports?
Compass Therapeutics, Inc. (CMPX)'s most recent 10-Q quarterly report was filed on May 5, 2026. SignalX displays every CMPX 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has CMPX filed recently?
Compass Therapeutics, Inc. (CMPX)'s most recent 8-K was filed on August 6, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find CMPX insider trading activity (Form 4)?
SignalX aggregates every CMPX Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does CMPX file with the SEC?
Compass Therapeutics, Inc. (CMPX) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new CMPX filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Compass Therapeutics, Inc. (CMPX).
What is CMPX's SEC CIK number?
Compass Therapeutics, Inc. (CMPX)'s SEC CIK (Central Index Key) number is 1738021. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1738021 to look up all CMPX filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Stay on top of Compass Therapeutics, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 53+ filings.